• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测无定形分散体系中的溶解度/混溶性:是时候超越规则溶液理论了。

Predicting Solubility/Miscibility in Amorphous Dispersions: It Is Time to Move Beyond Regular Solution Theories.

机构信息

Department of Pharmaceutical Sciences, University of Kentucky, Lexington, Kentucky 40506.

出版信息

J Pharm Sci. 2018 Jan;107(1):24-33. doi: 10.1016/j.xphs.2017.09.030. Epub 2017 Oct 12.

DOI:10.1016/j.xphs.2017.09.030
PMID:29031973
Abstract

The evolving challenges associated with the development of poorly soluble drug molecules have been met with major advances in drug solubilization. In particular, amorphous solid dispersion technology is becoming an increasingly important option to enhance oral bioavailability by creating prolonged drug supersaturation to maximize the driving force for intestinal absorption. A primary concern in the development of amorphous solid dispersions is their physical stability, leading to increasing interest in predictive methodologies to assess the propensity for drug crystallization under various storage conditions. For most drug-excipient combinations of pharmaceutical interest, hydrogen bonding is an important factor in determining miscibility, supersaturation potential, and the influence of water uptake during storage and after administration. The vast majority of publications to date have utilized mathematical models based on regular solution theory such as Flory-Huggins theory to predict drug-polymer miscibility, despite the fact that they were never intended to be applied to hydrogen-bonded systems. In this commentary article, regular solution theory is applied to simple hydrogen-bonded alcohol-alkane solutions to explore trends in the Flory-Huggins χ interaction parameter and possible pitfalls in its interpretation. More recent models that explicitly allow for specific interactions merit greater attention.

摘要

发展水溶性差的药物分子所带来的不断变化的挑战,已经在药物增溶方面取得了重大进展。特别是无定形固体分散技术正成为提高口服生物利用度的一种越来越重要的选择,通过创造延长的药物过饱和来最大限度地提高肠道吸收的驱动力。在无定形固体分散体的开发中,一个主要关注点是其物理稳定性,这导致人们越来越关注预测方法,以评估在各种储存条件下药物结晶的倾向。对于大多数具有药物赋形剂组合的药物,氢键是决定混溶性、过饱和度潜力以及在储存和给药后水摄取影响的重要因素。迄今为止,绝大多数出版物都利用基于规则溶液理论(如 Flory-Huggins 理论)的数学模型来预测药物-聚合物的混溶性,尽管它们从未打算应用于氢键系统。在这篇评论文章中,规则溶液理论被应用于简单的氢键醇-烷烃溶液,以探索 Flory-Huggins χ 相互作用参数的趋势和其解释中的可能陷阱。更最近的明确允许特定相互作用的模型值得更多关注。

相似文献

1
Predicting Solubility/Miscibility in Amorphous Dispersions: It Is Time to Move Beyond Regular Solution Theories.预测无定形分散体系中的溶解度/混溶性:是时候超越规则溶液理论了。
J Pharm Sci. 2018 Jan;107(1):24-33. doi: 10.1016/j.xphs.2017.09.030. Epub 2017 Oct 12.
2
Theoretical and experimental investigation of drug-polymer interaction and miscibility and its impact on drug supersaturation in aqueous medium.药物与聚合物相互作用及混溶性及其对水性介质中药物过饱和影响的理论与实验研究。
Eur J Pharm Biopharm. 2016 Oct;107:16-31. doi: 10.1016/j.ejpb.2016.06.024. Epub 2016 Jul 1.
3
Estimation of drug-polymer miscibility and solubility in amorphous solid dispersions using experimentally determined interaction parameters.利用实验测定的相互作用参数估算药物与聚合物在无定形固体分散体中的混溶性和溶解度。
Pharm Res. 2009 Jan;26(1):139-51. doi: 10.1007/s11095-008-9721-1. Epub 2008 Sep 9.
4
Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development.药物-聚合物的溶解度和混溶性:无定形固体分散体开发中的稳定性考虑和实际挑战。
J Pharm Sci. 2010 Jul;99(7):2941-7. doi: 10.1002/jps.22074.
5
A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.喷雾干燥和粉碎在磺胺噻唑/聚乙烯吡咯烷酮和磺胺嘧啶/聚乙烯吡咯烷酮无定形分散体制备中的比较。
Mol Pharm. 2011 Apr 4;8(2):532-42. doi: 10.1021/mp1003674. Epub 2011 Mar 3.
6
Prediction and Construction of Drug-Polymer Binary System Thermodynamic Phase Diagram in Amorphous Solid Dispersions (ASDs).预测和构建无定形固体分散体(ASD)中药物-聚合物二元体系的热力学相图。
AAPS PharmSciTech. 2022 Jun 17;23(6):169. doi: 10.1208/s12249-022-02319-4.
7
Investigation of phase diagrams and physical stability of drug-polymer solid dispersions.药物-聚合物固体分散体的相图及物理稳定性研究。
Pharm Dev Technol. 2015 Jan;20(1):105-17. doi: 10.3109/10837450.2014.949269. Epub 2014 Aug 12.
8
Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.利用 Flory-Huggins 相图作为制备无定形固体分散体的预配方工具:热熔挤出法和喷雾干燥法的比较。
J Pharm Pharmacol. 2014 Feb;66(2):256-74. doi: 10.1111/jphp.12141. Epub 2013 Nov 5.
9
Predicting the formation and stability of amorphous small molecule binary mixtures from computationally determined Flory-Huggins interaction parameter and phase diagram.从计算得出的 Flory-Huggins 相互作用参数和相图预测无定形小分子二元混合物的形成和稳定性。
Mol Pharm. 2010 Jun 7;7(3):795-804. doi: 10.1021/mp900304p.
10
Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.利用 Flory-Huggins 相互作用理论构建药物-聚合物热力学相图:确定温度和药物重量分数对固体分散体中相分离的相关性。
Mol Pharm. 2013 Jan 7;10(1):236-48. doi: 10.1021/mp300386v. Epub 2012 Dec 7.

引用本文的文献

1
Advancing amorphous solid dispersions through empirical and hybrid modeling of drug-polymer solubility and miscibility: A case study using Ibuprofen.通过药物-聚合物溶解度和混溶性的经验模型与混合模型推进无定形固体分散体:以布洛芬为例的案例研究
Int J Pharm X. 2025 Aug 9;10:100373. doi: 10.1016/j.ijpx.2025.100373. eCollection 2025 Dec.
2
Physics-Based Solubility Prediction for Organic Molecules.基于物理的有机分子溶解度预测
Chem Rev. 2025 Aug 13;125(15):7057-7098. doi: 10.1021/acs.chemrev.4c00855. Epub 2025 Jul 29.
3
COSMOPharm: Drug-Polymer Compatibility of Pharmaceutical Amorphous Solid Dispersions from COSMO-SAC.
COSMOPharm:COSMO-SAC 法评估药物聚合物的药用无定形固体分散体的相容性。
Mol Pharm. 2024 Sep 2;21(9):4395-4415. doi: 10.1021/acs.molpharmaceut.4c00342. Epub 2024 Jul 30.
4
Composition Dependency of the Flory-Huggins Interaction Parameter in Drug-Polymer Phase Behavior.药物-聚合物相行为中弗洛里-哈金斯相互作用参数的组成依赖性
Pharmaceutics. 2023 Nov 21;15(12):2650. doi: 10.3390/pharmaceutics15122650.
5
Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology.利用无定形固体分散技术解决研发阶段的药物制剂问题。
Recent Adv Drug Deliv Formul. 2024;18(2):79-99. doi: 10.2174/0126673878271641231201065151.
6
The Use of Hot Melt Extrusion to Prepare a Solid Dispersion of Ibuprofen in a Polymer Matrix.采用热熔挤出法制备布洛芬在聚合物基质中的固体分散体。
Polymers (Basel). 2023 Jun 30;15(13):2912. doi: 10.3390/polym15132912.
7
Tailored ASD destabilization - Balancing shelf life stability and dissolution performance with hydroxypropyl cellulose.定制的动脉粥样硬化斑块不稳定化——用羟丙基纤维素平衡保质期稳定性和溶解性能。
Int J Pharm X. 2023 Jun 7;5:100187. doi: 10.1016/j.ijpx.2023.100187. eCollection 2023 Dec.
8
Can Pure Predictions of Activity Coefficients from PC-SAFT Assist Drug-Polymer Compatibility Screening?纯从 PC-SAFT 预测活度系数能否有助于药物-聚合物相容性筛选?
Mol Pharm. 2023 Aug 7;20(8):3960-3974. doi: 10.1021/acs.molpharmaceut.3c00124. Epub 2023 Jun 29.
9
Amorphous Solid Dispersions: Role of the Polymer and Its Importance in Physical Stability and In Vitro Performance.无定形固体分散体:聚合物的作用及其在物理稳定性和体外性能方面的重要性。
Pharmaceutics. 2022 Aug 22;14(8):1747. doi: 10.3390/pharmaceutics14081747.
10
Simultaneously Embedding Indomethacin and Electrodeposition of Polypyrrole on Various CoCr Alloys from Ionic Liquids.在离子液体中同时将吲哚美辛嵌入及聚吡咯电沉积到各种钴铬合金上。
Materials (Basel). 2022 Jul 5;15(13):4714. doi: 10.3390/ma15134714.